(-0.02%) 5 468.35 points
(-0.03%) 39 100 points
(0.26%) 17 764 points
(-0.53%) $80.40
(-4.32%) $2.64
(-0.85%) $2 311.10
(-0.05%) $28.86
(2.27%) $1 008.80
(0.28%) $0.936
(0.68%) $10.68
(0.47%) $0.792
(-0.16%) $87.35
Live Chart Being Loaded With Signals
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis...
Stats | |
---|---|
Today's Volume | 167 249 |
Average Volume | 723 914 |
Market Cap | 1.73B |
EPS | $-0.0249 ( Q4 | 2024-05-08 ) |
Next earnings date | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-24.27 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0300 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-13 | Jones Evan/ Fa | Buy | 11 473 | Common Stock |
2024-06-13 | Barr Eliav | Buy | 11 473 | Common Stock |
2024-06-13 | Holstein Jens | Buy | 11 473 | Common Stock |
2024-06-13 | Bhanji Muna | Buy | 11 473 | Common Stock |
2024-06-13 | Epstein Robert S | Buy | 11 473 | Common Stock |
INSIDER POWER |
---|
41.81 |
Last 99 transactions |
Buy: 1 110 167 | Sell: 494 154 |
Volume Correlation
Veracyte Inc Correlation
10 Most Positive Correlations | |
---|---|
SPTN | 0.938 |
SGBX | 0.938 |
RRGB | 0.931 |
AGRX | 0.928 |
AMCX | 0.924 |
BIIB | 0.922 |
VIOT | 0.921 |
CNXC | 0.919 |
TBNK | 0.919 |
QNRX | 0.918 |
10 Most Negative Correlations | |
---|---|
MTEK | -0.921 |
KINS | -0.918 |
VNOM | -0.911 |
JSPR | -0.91 |
TAYD | -0.907 |
CDRO | -0.907 |
JVA | -0.904 |
RNA | -0.903 |
IMPPP | -0.903 |
SHLD | -0.901 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Veracyte Inc Correlation - Currency/Commodity
Veracyte Inc Financials
Annual | 2023 |
Revenue: | $361.05M |
Gross Profit: | $223.15M (61.81 %) |
EPS: | $-1.020 |
FY | 2023 |
Revenue: | $361.05M |
Gross Profit: | $223.15M (61.81 %) |
EPS: | $-1.020 |
FY | 2022 |
Revenue: | $296.54M |
Gross Profit: | $194.95M (65.74 %) |
EPS: | $-0.510 |
FY | 2021 |
Revenue: | $219.51M |
Gross Profit: | $145.11M (66.11 %) |
EPS: | $-1.419 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Veracyte Inc
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators